A Long-Term Survivor With Alveolar Capillary Dysplasia

Area of Science:

• Cardiology
• Pediatric Pulmonology
• Medical Therapy

Background:

• Alveolar capillary dysplasia (ACD) is a rare, severe congenital disorder characterized by abnormal development of pulmonary capillaries.
• It leads to severe pulmonary hypertension and right heart failure, often with a poor prognosis.

Observation:

• A case study of a patient with alveolar capillary dysplasia who has survived for over 56 months.
• The patient received a combination of medical therapies, including endothelin receptor antagonists and amlodipine.

Findings:

• Intrauterine exposure to metformin may have influenced the severity of alveolar capillary dysplasia.
• Endothelin receptor antagonists and amlodipine were crucial in reducing pulmonary arterial pressure and managing right heart failure.
• Sustained medical management allowed for prolonged survival beyond typical expectations for this condition.

Implications:

• This case highlights the potential benefit of specific medical therapies in managing severe pulmonary hypertension in alveolar capillary dysplasia.
• The findings suggest a possible protective role of intrauterine metformin exposure, warranting further investigation.
• Long-term survival is achievable with aggressive and tailored medical management strategies for rare pediatric lung diseases.